|
L7045
|
|
L 748337 hydrate ≥98% (HPLC)
|
L 748337 is a selective, competitive beta 3 adrenergic receptor antagonist, that binds to the receptor with an affinity of 04 nM. The affinities for beta-1 and beta-2 receptors are 154 and 204 nM, respectively. The compound potently inhibits agonist-stimulated lipolysis in adipocytes, as well as agonist induced relaxation of smooth muscle.
|
|
|
|
|
|
A6351
|
|
A-315456 >98% (HPLC), solid
|
Selective α1D-adrenoceptor antagonist.
|
human ... ADRA1D(146)
|
|
|
|
|
A0232
|
|
Alfuzosin hydrochloride ≥98% (HPLC), solid
|
Alfuzosin hydrochloride is an alpha-adrenergic blocker used to treat benign prostatic hyperplasia (BPH). It works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate.
|
|
|
|
|
|
A5736
|
|
ARC 239 dihydrochloride hydrate ≥98% (HPLC)
|
ARC 239 is a selective α-2B adrenergic blocker. Although ARC-239, like prazosin, also has some alpha-1 antagonist activity, it is used most commomly to differentiate alpha-2A/D from alpha-2B and alpha-2C subtypes rather than for any alpha-1 inhibition..
|
|
|
|
|
|
A7655
|
|
Atenolol ≥98% (TLC), powder
|
Selective β1-adrenoceptor antagonist; antihypertensive; antianginal; antiarrhythmic.
|
human ... ADRB1(153) rat ... Adrb1(24925)
|
|
|
|
|
A143
|
|
(S)-(−)-Atenolol powder
|
β1-Adrenergic receptor antagonist; active enantiomer of atenolol.
|
human ... ADRB1(153)
|
|
|
|
|
B016
|
|
Benoxathian hydrochloride solid
|
Selective α1-adrenoceptor antagonist.
|
human ... ADRA1A(148), ADRA1B(147), ADRA1D(146)
|
|
|
|
|
B5683
|
|
Betaxolol hydrochloride >98% (HPLC)
|
Selective β1 adrenoceptor antagonist.
|
human ... ADRB1(153)
|
|
|
|
|
B2185
|
|
Bisoprolol hemifumarate salt ≥98% (HPLC), solid
|
Cardioselective β1-adrenoceptor antagonist.
|
|
|
|
|
|
B134
|
|
BMY 7378 dihydrochloride ≥98% (HPLC), solid
|
BMY 7378 dihydrochloride is a partial 5-HT1A serotonin receptor agonist and selective α1D-adrenoceptor antagonist.
|
human ... ADRA1D(146), HTR1A(3350)
|
|
|
|
|
B4559
|
|
BRL 44408 maleate salt ≥98% (HPLC)
|
BRL 44408 maleate is a selective α2A-adrenoceptor antagonist.
|
|
|
|
|
|
C231
|
|
CGP-20712A methanesulfonate salt solid, ≥98% (HPLC)
|
CGP-20712A methanesulfonate salt is a selective β1-adrenoceptor antagonist.
|
human ... ADRB1(153)
|
|
|
|
|
C247
|
|
Cyclazosin hydrochloride solid
|
α1B-adrenoceptor antagonist.
|
|
|
|
|
|
D9815
|
|
Doxazosin mesylate ≥97% (HPLC), powder
|
α1-adrenoceptor antagonist; relaxes smooth muscles of the prostate
|
human ... ADRA1A(148), ADRA1B(147), ADRA1D(146) rat ... Adra1a(29412), Adra1b(24173), Adra1d(29413)
|
|
|
|
|
F4303
|
|
Fiduxosin hydrochloride >98% (HPLC), solid
|
α1-Adrenoceptor antagonist.
|
human ... ADRA1A(148), ADRA1B(147), ADRA1D(146)
|
|
|
|
|
I127
|
|
ICI 118,551 hydrochloride ≥98% (HPLC), powder
|
ICI 118,551 hydrochloride is a highly selective β2-adrenoceptor antagonist.
|
human ... ADRB2(154)
|
|
|
|
|
I9531
|
|
Imiloxan hydrochloride >98% (HPLC), solid
|
Selective α2B-adrenoceptor antagonist.
|
human ... ADRA2B(151)
|
|
|
|
|
I2909
|
|
Indoramin hydrochloride ≥98% (HPLC), solid
|
α1-adrenoceptor antagonist.
|
|
|
|
|
|
L3040
|
|
L-765,314 hydrate ≥98% (HPLC), solid
|
Potent and selective α1B-adrenoceptor antagonist.
|
human ... ADRA1A(148), ADRA1B(147), ADRA1D(146) rat ... Adra1a(29412), Adra1b(24173), Adra1d(29413)
|
|
|
|
|
L1011
|
|
Labetalol hydrochloride >98% (TLC), powder
|
Competitive β-adrenoceptor antagonist.
|
human ... ADRB1(153), ADRB2(154), ADRB3(155)
|
|
|
|
|
U101
|
|
5-Methylurapidil solid
|
Selective α1A-adrenoceptor antagonist; antihypertensive.
|
human ... ADRA1A(148), ADRA1B(147), ADRA1D(146)
|
|
|
|
|
M5391
|
|
(±)-Metoprolol (+)-tartrate salt ≥98% (titration), powder
|
β1-adrenoceptor antagonist.
|
human ... ADRB1(153)
|
|
|
|
|
M5154
|
|
Moxisylyte hydrochloride >99% (TLC), powder
|
α1-adrenoceptor antagonist; peripheral vasodilator.
|
human ... ADRA1A(148), ADRA1B(147), ADRA1D(146)
|
|
|
|
|
N158
|
|
Naftopidil hydrochloride hydrate solid
|
α1-Adrenoceptor antagonist; antihypertensive.
|
human ... ADRA1A(148), ADRA1B(147), ADRA1D(146)
|
|
|
|
|
N135
|
|
S(+)-Niguldipine hydrochloride solid
|
α1A-adrenoceptor antagonist; antihypertensive agent; L-type Ca2+ channel blocker; potassium agonist that activates Ca2+-activated maxi K-channels.
|
|
|
|
|
|
B019
|
|
Phenoxybenzamine hydrochloride ≥97%, powder
|
Calmodulin antagonist; α-adrenoceptor antagonist.
|
human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152)
|
|
|
|
|
P7547
|
|
Phentolamine hydrochloride ≥98% (TLC), powder
|
α-adrenoceptor antagonist; peripheral vasodilator.
|
|
|
|
|
|
P7561
|
|
Phentolamine methanesulfonate salt ≥98% (TLC), powder
|
α-Adrenergic receptor antagonist; peripheral vasodilator.
|
human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152)
|
|
|
|
|
P0778
|
|
Pindolol ≥98% (TLC), powder
|
β1-adrenoceptor antagonist; putative 5-HT1A serotonin receptor agonist; vasodilator.
|
human ... ADRB1(153), HTR1A(3350)
|
|
|
|
|
P152
|
|
S(–)-Pindolol solid
|
β1-adrenoceptor antagonist; putative 5-HT1A serotonin receptor agonist; vasodilator. Active enantiomer of pindolol.
|
human ... ADRB1(153), HTR1A(3350), HTR1B(3351)
|
|
|
|
|
P7791
|
|
Prazosin hydrochloride ≥99% (TLC)
|
Peripheral α1-adrenoceptor antagonist; vasodilator.
|
human ... ADRA1A(148), ADRA1B(147), ADRA1D(146)
|
|
|
|
|
P0689
|
|
(R)-(+)-Propranolol hydrochloride ≥98% (TLC)
|
Less active enantiomer of propranolol.
|
|
|
|
|
|
P8688
|
|
(S)-(−)-Propranolol hydrochloride ≥98% (TLC), powder
|
Active β-adrenoceptor blocking enantiomer, as measured by inhibition of isoprenaline-induced tachycardia; Propranolol is also non-specific 5-HT1A, 5-HT1B and 5-HT1C serotonin receptor antagonist. The stereoselective association of mianserin and propranolol with the 5HT1A, 5HT1B and 5HT1C sites may prove useful in the characterization of these sites
|
human ... ADRB1(153), ADRB2(154), ADRB3(155), HTR1A(3350), HTR1B(3351), HTR1D(3352), HTR1E(3354), HTR1F(3355)
|
|
|
|
|
P0884
|
|
(±)-Propranolol hydrochloride ≥99% (TLC), powder
|
β-adrenoceptor antagonist; 5-HT1/5-HT2 serotonin receptor antagonist; cardiac depressant (anti-arrhythmic).
|
human ... ADRB1(153), ADRB2(154), ADRB3(155), HTR1A(3350), HTR1B(3351), HTR1D(3352), HTR1E(3354), HTR1F(3355), HTR2A(3356), HTR2B(3357), HTR2C(3358)
|
|
|
|
|
R9525
|
|
RX 821002 hydrochloride solid, ≥98% (HPLC)
|
Selective α2-adrenoceptor antagonist
|
human ... ADRA2A(150), ADRA2B(151), ADRA2C(152)
|
|
|
|
|
S1563
|
|
SKF-86466 hydrochloride solid, ≥98% (HPLC)
|
Potent and selective α2 adrenoceptor antagonist.
|
human ... ADRA2A(150), ADRA2B(151), ADRA2C(152)
|
|
|
|
|
S0278
|
|
(±)-Sotalol hydrochloride ≥98% (TLC), powder
|
Potent β-adrenoceptor antagonist; class III antiarrhythmic; prolongs the action potential and increases the refractory period.
|
human ... ADRB1(153), ADRB2(154), ADRB3(155)
|
|
|
|
|
S8688
|
|
SR 59230A ≥98% (HPLC), powder
|
SR 59230A is a β3-adrenoceptor antagonist.
|
human ... ADRB3(155)
|
|
|
|
|
T4680
|
|
Terazosin hydrochloride ≥98% (TLC), powder
|
α1-adrenoceptor antagonist.
|
human ... ADRA1A(148), ADRA1B(147), ADRA1D(146)
|
|
|
|
|
T6394
|
|
Timolol maleate salt ≥98% (TLC), powder
|
Non-selective β-adrenoceptor antagonist; vasodilator; class II anti-arrhythmic; anti-glaucoma agent
|
human ... ADRB1(153), ADRB2(154), ADRB3(155)
|
|
|
|
|
U100
|
|
Urapidil hydrochloride solid
|
α1-adrenoceptor antagonist; 5-HT1A serotonin receptor partial agonist; anti-hypertensive.
|
human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), HTR1A(3350)
|
|
|
|
|
Y3125
|
|
Yohimbine hydrochloride ≥98% (TLC), powder
|
α2-adrenoceptor antagonist.
|
human ... ADRA2A(150), ADRA2B(151), ADRA2C(152)
|
|
|
|